The Global Fund To Fight Aids, Tuberculosis And Malaria (The Global Fund) 2023 SR
The report highlights the Global Fund's progress and recovery in the fight against HIV, tuberculosis, and malaria in 2022, following setbacks from the COVID-19 pandemic. By the end of 2022, the partnership helped save 59 million lives and reduced the combined death rate of the three diseases by 55% since 2002. The report emphasizes the need to build resilient and sustainable systems for health, address climate change impacts, and tackle human rights and gender inequalities. Additionally, the Global Fund achieved a record-breaking Seventh Replenishment pledge of US$15.7 billion and disbursed a record US$5.2 billion in 2022.
Company: The Global Fund To Fight Aids, Tuberculosis And Malaria (The Global Fund)
Sector: Government, defence & social security
Country: Switzerland
Year: 2023
Type: SR
Pages: 112
Back to company
The Global Fund To Fight Aids, Tuberculosis And Malaria (The Global Fund)
Results Report
The report highlights the Global Fund's progress and recovery in the fight against HIV, tuberculosis, and malaria in 2022, following setbacks from the COVID-19 pandemic. By the end of 2022, the partnership helped save 59 million lives and reduced the combined death rate of the three diseases by 55% since 2002. The report emphasizes the need to build resilient and sustainable systems for health, address climate change impacts, and tackle human rights and gender inequalities. Additionally, the Global Fund achieved a record-breaking Seventh Replenishment pledge of US$15.7 billion and disbursed a record US$5.2 billion in 2022.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available